Home » Topics » BioWorld Science

BioWorld Science
RSS

CSIC, University of Glasgow present trypanosomal alternative oxidase inhibitors

May 10, 2018

Novartis patents novel HBV HBsAg secretion inhibitors

May 10, 2018

Regeneron presents novel REGN-4018 antibody for ovarian cancer

May 10, 2018

New EAAT3 inhibitors divulged by Roche

May 10, 2018

Lundbeck updates pipeline progress of first quarter 2018

May 10, 2018

Syndax Pharmaceuticals describes preclinical activity of Menin/MLL1 inhibitor VTP-50469

May 10, 2018

Lodo Therapeutics and Genentech enter multi-target strategic collaboration

May 10, 2018

Escient Pharmaceuticals launches to advance first-in-class GPCR-targeted drugs

May 10, 2018

Novel NKCC1 inhibitor reduces brain damage after ischemic stroke in mice

May 10, 2018

Lipocine receives FDA complete response letter for Tlando

May 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...